Objectives Geriatric population, namely people aged 80 or older, is going to see the greatest growth over the next years. The standard treatment cannot be implemented for all the geriatric women with gynecological cancer and it depends on multiple factors such as physiological organ function as well as comorbidities. The aim of this study is to examine the status of treatment strategies among our cohort of geriatric patients.

Methods A retrospective analysis of geriatric patients with gynecologic cancer who were treated in our department (Department of Gynecologic Oncology, Metaxa Cancer Hospital, Greece) between January 2008 and January 2020 was conducted.

Results 165 geriatric patients were included in our study with the vast majority being between 80 and 90 years old. The highest number of patients consisted of individuals with vulvar caner- 53 cases (32.1%). The corpus uteri cancer (endometrial and uterine sarcomas) group follows right after the vulvar cancer group with 52 cases (31.5%). Ovarian cancer was diagnosed in 31 patients (18.8%) and cervical cancer in 29 patients (17.6%). Different treatment modalities, depending on the ECOG performance status scale and the FIFE (Frailty Index For Elders) score as well as the tumor stage (FIGO Classification) and the tumor grade of differentiation, are being presented.

Conclusions A more individualized treatment strategy according to a comprehensive geriatric assessment is suggested for geriatric patients with gynecological cancer.